Ubs Group Ag Eye Point Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 189,903 shares of EYPT stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,903

Previous 456,626 58.41%

Holding current value

$1.52 Million

Previous $9.44 Million 82.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$8.16 - $22.89 $2.18 Million - $6.11 Million	-266,723 Reduced 58.41%	189,903 $1.65 Million
Q1 2024 May 13, 2024	SELL	$19.93 - $29.71 $2.34 Million - $3.49 Million	-117,543 Reduced 20.47%	456,626 $9.44 Million
Q4 2023 Feb 09, 2024	BUY	$5.71 - $24.13 $270,202 - $1.14 Million	47,321 Added 8.98%	574,169 $13.3 Million
Q3 2023 Nov 09, 2023	BUY	$7.99 - $15.36 $3.49 Million - $6.72 Million	437,190 Added 487.62%	526,848 $4.21 Million
Q2 2023 Aug 11, 2023	BUY	$3.03 - $9.0 $269,542 - $800,622	88,958 Added 12708.29%	89,658 $780,000
Q4 2022 Feb 08, 2023	BUY	$2.37 - $7.2 $237 - $720	100 Added 16.67%	700 $2,000
Q2 2022 Aug 10, 2022	SELL	$7.25 - $12.71 $6,699 - $11,744	-924 Reduced 60.63%	600 $5,000
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $267,278 - $434,983	-30,828 Reduced 95.29%	1,524 $18,000
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $319,000 - $576,582	31,336 Added 3084.25%	32,352 $396,000
Q3 2021 Nov 15, 2021	SELL	$7.51 - $11.72 $5,482 - $8,555	-730 Reduced 41.81%	1,016 $10,000
Q2 2021 Aug 13, 2021	BUY	$8.69 - $11.08 $10,819 - $13,794	1,245 Added 248.5%	1,746 $16,000
Q1 2021 May 12, 2021	BUY	$8.89 - $14.92 $8 - $14	1 Added 0.2%	501 $5,000
Q4 2020 Feb 11, 2021	BUY	$3.7 - $6.58 $1,850 - $3,290	500 New	500 $3,000

Others Institutions Holding EYPT

# of Institutions

163

Shares Held

58.2M

Call Options Held

224K

Put Options Held

1.41M

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $272M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account